Chinese medicine is a wonderful jewel of the Chinese nation for 5,000 years. However, until now, there has been no Chinese patent medicine exported to the mainstream markets in Europe and America. In the face of this embarrassment, experts who came to Hangzhou to participate in the Fourth China-US Pharmacopoeia International Forum today said that if Chinese medicine is to go to the international market, there is an urgent need to further improve the quality standards and keep up with international standards. China, as a big Chinese medicine country, has the world’s largest production capacity and raw materials, but its export volume accounts for only about 5% of the world’s Chinese medicine market, and most of it is the export of raw materials and semi-finished products. The countries of Korea, Japan, the United States, and Germany process it into The finished products with higher added value will be sold back to China at high prices and become so-called “Chinese medicinesâ€. "Pills, powders, creams, and dan, the gods are difficult to distinguish." Professor Zhong Zhongzhi, Director of the Chinese Medicines Standards Division of the National Pharmacopoeia Commission, said that compared with Western medicine, the quality control of Chinese medicine is indeed more difficult, because the ingredients in Chinese medicine are very complex, with different growing locations and different climate changes, all of which may lead to changes in Chinese herbal ingredients. While Western medicine studies are mainly single components, it is relatively easier. How to establish a quality standard system for Chinese medicine that meets the characteristics of Chinese medicine and allows the international community to recognize it is the key to China's modernization of Chinese medicine and to the international market. Qian Zhongzhi said that the 2010 edition of the "Chinese Pharmacopoeia" formally implemented on October 1 this year has stricter provisions on the quality standards of Chinese medicine. At the same time, China is speeding up the development of a quality standard system for Chinese medicines that is in line with international advanced standards. According to the person in charge of the State Food and Drug Administration, at present, the U.S. Pharmacopoeia has confirmed that five varieties of drugs such as Andrographis, Centella asiatica, Cinnamon, Artemisia annua and Ganoderma lucidum are collected in the United States Pharmacopoeia, Sanqi, Quanquan and Safflower. Four kinds of Chinese medicines, such as mantle, are also accepted by the European Pharmacopoeia. This means that these Chinese medicines already have a “green fast track†that has entered the international market, and the registration and approval procedures for entering the international market can be greatly shortened.
Sterile Medical Lap Sponges
Structure and composition: It is made of 100% Cotton Gauze, cotton tape, X-ray or X-ray film by degreasing, bleaching, drying, processing, cutting, folding and sewing.
Product performance: White, soft, non-toxic, odorless, non-fluorescent, no oil spots, no whiskers, no hair corners, no wrinkles or debris adhesion, and has good water absorption performance.
Model specifications: Sterile type, washed or not washed. The color is mainly white, supplemented by blue and green. Specifications are divided into 30 * 30CM-4 / 6/8/12, 45 * 45-4 / 6/8/12, 50 * 50-4 / 6/8/12, 30 * 40/40 * 45, etc., with or without belt; with or without light, can be sewn based on different requirements
Packing: Each 1-5 pieces are packaged with medical crepe paper or medical blue film, and then packed into medical paper-plastic / paper paper bags or medical blister packaging, with 5-layer double corrugated kraft paper boxes.
Scope of application: It is used for one-time use by medical institutions for surgery or protection.
Lap Pad Sponge,Cotton Lap Sponge,Sterile Lap Sponges,Surgery Abdominal Swabs Shaoxing Gangfeng Hospital Products Co.,Ltd. , https://www.gangfenggauze.com